nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Vismodegib—skin cancer	0.16	0.557	CbGbCtD
Cilazapril—ABCB1—Dactinomycin—skin cancer	0.0842	0.292	CbGbCtD
Cilazapril—ABCB1—Docetaxel—skin cancer	0.0435	0.151	CbGbCtD
Cilazapril—ACE—forelimb zeugopod—skin cancer	0.0375	0.204	CbGeAlD
Cilazapril—ACE—forelimb—skin cancer	0.0189	0.102	CbGeAlD
Cilazapril—ACE—hindlimb—skin cancer	0.017	0.0921	CbGeAlD
Cilazapril—ACE—arm—skin cancer	0.0162	0.088	CbGeAlD
Cilazapril—ACE—appendage—skin cancer	0.0146	0.079	CbGeAlD
Cilazapril—ACE—nerve—skin cancer	0.0103	0.056	CbGeAlD
Cilazapril—ACE—endothelium—skin cancer	0.00878	0.0477	CbGeAlD
Cilazapril—ACE—blood vessel—skin cancer	0.0081	0.044	CbGeAlD
Cilazapril—ACE—neck—skin cancer	0.00579	0.0315	CbGeAlD
Cilazapril—SLC15A1—epithelium—skin cancer	0.0055	0.0299	CbGeAlD
Cilazapril—SLC15A1—mammalian vulva—skin cancer	0.00477	0.0259	CbGeAlD
Cilazapril—ACE—connective tissue—skin cancer	0.00415	0.0226	CbGeAlD
Cilazapril—ACE—epithelium—skin cancer	0.00394	0.0214	CbGeAlD
Cilazapril—ACE—mammalian vulva—skin cancer	0.00342	0.0186	CbGeAlD
Cilazapril—ACE—lymphoid tissue—skin cancer	0.00304	0.0165	CbGeAlD
Cilazapril—ACE—female reproductive system—skin cancer	0.00293	0.0159	CbGeAlD
Cilazapril—ABCB1—blood vessel—skin cancer	0.00285	0.0155	CbGeAlD
Cilazapril—SLC15A2—female reproductive system—skin cancer	0.00255	0.0139	CbGeAlD
Cilazapril—ACE—head—skin cancer	0.00245	0.0133	CbGeAlD
Cilazapril—SLC15A2—head—skin cancer	0.00213	0.0116	CbGeAlD
Cilazapril—ACE—lymph node—skin cancer	0.00171	0.0093	CbGeAlD
Cilazapril—SLC15A2—lymph node—skin cancer	0.00149	0.00811	CbGeAlD
Cilazapril—ABCB1—epithelium—skin cancer	0.00139	0.00754	CbGeAlD
Cilazapril—ABCB1—mammalian vulva—skin cancer	0.0012	0.00654	CbGeAlD
Cilazapril—ABCB1—lymphoid tissue—skin cancer	0.00107	0.0058	CbGeAlD
Cilazapril—ABCB1—female reproductive system—skin cancer	0.00103	0.0056	CbGeAlD
Cilazapril—Pharyngitis—Temozolomide—skin cancer	0.000994	0.00188	CcSEcCtD
Cilazapril—Chills—Dactinomycin—skin cancer	0.000994	0.00188	CcSEcCtD
Cilazapril—Urinary tract disorder—Temozolomide—skin cancer	0.000989	0.00187	CcSEcCtD
Cilazapril—Cardiac failure—Docetaxel—skin cancer	0.000987	0.00187	CcSEcCtD
Cilazapril—Pruritus—Vemurafenib—skin cancer	0.000985	0.00187	CcSEcCtD
Cilazapril—Urethral disorder—Temozolomide—skin cancer	0.000982	0.00186	CcSEcCtD
Cilazapril—Alopecia—Dactinomycin—skin cancer	0.000979	0.00185	CcSEcCtD
Cilazapril—Feeling abnormal—Imiquimod—skin cancer	0.000979	0.00185	CcSEcCtD
Cilazapril—Gastrointestinal pain—Imiquimod—skin cancer	0.000971	0.00184	CcSEcCtD
Cilazapril—Epistaxis—Fluorouracil—skin cancer	0.00097	0.00184	CcSEcCtD
Cilazapril—Visual impairment—Temozolomide—skin cancer	0.000965	0.00183	CcSEcCtD
Cilazapril—Sinusitis—Fluorouracil—skin cancer	0.000964	0.00183	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000963	0.00182	CcSEcCtD
Cilazapril—Agranulocytosis—Fluorouracil—skin cancer	0.000959	0.00182	CcSEcCtD
Cilazapril—Ill-defined disorder—Bleomycin—skin cancer	0.000959	0.00182	CcSEcCtD
Cilazapril—Anaemia—Bleomycin—skin cancer	0.000955	0.00181	CcSEcCtD
Cilazapril—Diarrhoea—Vemurafenib—skin cancer	0.000953	0.0018	CcSEcCtD
Cilazapril—Migraine—Docetaxel—skin cancer	0.000948	0.00179	CcSEcCtD
Cilazapril—Erythema multiforme—Temozolomide—skin cancer	0.000947	0.00179	CcSEcCtD
Cilazapril—Urticaria—Imiquimod—skin cancer	0.000943	0.00179	CcSEcCtD
Cilazapril—Abdominal pain—Imiquimod—skin cancer	0.000939	0.00178	CcSEcCtD
Cilazapril—Tinnitus—Temozolomide—skin cancer	0.000934	0.00177	CcSEcCtD
Cilazapril—Malaise—Bleomycin—skin cancer	0.000932	0.00177	CcSEcCtD
Cilazapril—Flushing—Temozolomide—skin cancer	0.00093	0.00176	CcSEcCtD
Cilazapril—Cardiac disorder—Temozolomide—skin cancer	0.00093	0.00176	CcSEcCtD
Cilazapril—Leukopenia—Bleomycin—skin cancer	0.000925	0.00175	CcSEcCtD
Cilazapril—Rhinitis—Fluorouracil—skin cancer	0.000925	0.00175	CcSEcCtD
Cilazapril—Dizziness—Vemurafenib—skin cancer	0.000921	0.00174	CcSEcCtD
Cilazapril—Hypoaesthesia—Fluorouracil—skin cancer	0.000918	0.00174	CcSEcCtD
Cilazapril—Pharyngitis—Fluorouracil—skin cancer	0.000916	0.00173	CcSEcCtD
Cilazapril—Angiopathy—Temozolomide—skin cancer	0.000909	0.00172	CcSEcCtD
Cilazapril—Ataxia—Docetaxel—skin cancer	0.000905	0.00171	CcSEcCtD
Cilazapril—Immune system disorder—Temozolomide—skin cancer	0.000905	0.00171	CcSEcCtD
Cilazapril—Cough—Bleomycin—skin cancer	0.000902	0.00171	CcSEcCtD
Cilazapril—Chills—Temozolomide—skin cancer	0.000899	0.0017	CcSEcCtD
Cilazapril—Ill-defined disorder—Dactinomycin—skin cancer	0.000894	0.00169	CcSEcCtD
Cilazapril—Anaemia—Dactinomycin—skin cancer	0.000891	0.00169	CcSEcCtD
Cilazapril—Liver function test abnormal—Docetaxel—skin cancer	0.000889	0.00168	CcSEcCtD
Cilazapril—Vomiting—Vemurafenib—skin cancer	0.000885	0.00168	CcSEcCtD
Cilazapril—Alopecia—Temozolomide—skin cancer	0.000885	0.00168	CcSEcCtD
Cilazapril—Chest pain—Bleomycin—skin cancer	0.00088	0.00167	CcSEcCtD
Cilazapril—Myalgia—Bleomycin—skin cancer	0.00088	0.00167	CcSEcCtD
Cilazapril—Orthostatic hypotension—Docetaxel—skin cancer	0.000879	0.00167	CcSEcCtD
Cilazapril—Rash—Vemurafenib—skin cancer	0.000878	0.00166	CcSEcCtD
Cilazapril—Dermatitis—Vemurafenib—skin cancer	0.000877	0.00166	CcSEcCtD
Cilazapril—Hypersensitivity—Imiquimod—skin cancer	0.000875	0.00166	CcSEcCtD
Cilazapril—Headache—Vemurafenib—skin cancer	0.000872	0.00165	CcSEcCtD
Cilazapril—Discomfort—Bleomycin—skin cancer	0.000869	0.00165	CcSEcCtD
Cilazapril—Malaise—Dactinomycin—skin cancer	0.000869	0.00165	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000867	0.00164	CcSEcCtD
Cilazapril—Leukopenia—Dactinomycin—skin cancer	0.000863	0.00163	CcSEcCtD
Cilazapril—ABCB1—head—skin cancer	0.000861	0.00468	CbGeAlD
Cilazapril—Dysgeusia—Temozolomide—skin cancer	0.000854	0.00162	CcSEcCtD
Cilazapril—Asthenia—Imiquimod—skin cancer	0.000852	0.00161	CcSEcCtD
Cilazapril—Confusional state—Bleomycin—skin cancer	0.000851	0.00161	CcSEcCtD
Cilazapril—Oedema—Bleomycin—skin cancer	0.000844	0.0016	CcSEcCtD
Cilazapril—Pruritus—Imiquimod—skin cancer	0.00084	0.00159	CcSEcCtD
Cilazapril—Nausea—Vemurafenib—skin cancer	0.000827	0.00157	CcSEcCtD
Cilazapril—Thrombocytopenia—Bleomycin—skin cancer	0.000826	0.00156	CcSEcCtD
Cilazapril—Arrhythmia—Fluorouracil—skin cancer	0.000824	0.00156	CcSEcCtD
Cilazapril—Myalgia—Dactinomycin—skin cancer	0.000821	0.00155	CcSEcCtD
Cilazapril—Bronchospasm—Docetaxel—skin cancer	0.000819	0.00155	CcSEcCtD
Cilazapril—Tremor—Temozolomide—skin cancer	0.000817	0.00155	CcSEcCtD
Cilazapril—Alopecia—Fluorouracil—skin cancer	0.000815	0.00154	CcSEcCtD
Cilazapril—Diarrhoea—Imiquimod—skin cancer	0.000812	0.00154	CcSEcCtD
Cilazapril—Discomfort—Dactinomycin—skin cancer	0.000811	0.00154	CcSEcCtD
Cilazapril—Angina pectoris—Docetaxel—skin cancer	0.000811	0.00154	CcSEcCtD
Cilazapril—Ill-defined disorder—Temozolomide—skin cancer	0.000809	0.00153	CcSEcCtD
Cilazapril—Anaemia—Temozolomide—skin cancer	0.000806	0.00153	CcSEcCtD
Cilazapril—Anorexia—Bleomycin—skin cancer	0.000804	0.00152	CcSEcCtD
Cilazapril—Angioedema—Temozolomide—skin cancer	0.000797	0.00151	CcSEcCtD
Cilazapril—Hypotension—Bleomycin—skin cancer	0.000788	0.00149	CcSEcCtD
Cilazapril—Oedema—Dactinomycin—skin cancer	0.000787	0.00149	CcSEcCtD
Cilazapril—Malaise—Temozolomide—skin cancer	0.000786	0.00149	CcSEcCtD
Cilazapril—Dizziness—Imiquimod—skin cancer	0.000785	0.00149	CcSEcCtD
Cilazapril—Vertigo—Temozolomide—skin cancer	0.000783	0.00148	CcSEcCtD
Cilazapril—Leukopenia—Temozolomide—skin cancer	0.00078	0.00148	CcSEcCtD
Cilazapril—Neutropenia—Docetaxel—skin cancer	0.000778	0.00147	CcSEcCtD
Cilazapril—Palpitations—Temozolomide—skin cancer	0.000771	0.00146	CcSEcCtD
Cilazapril—Thrombocytopenia—Dactinomycin—skin cancer	0.00077	0.00146	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000769	0.00146	CcSEcCtD
Cilazapril—Cough—Temozolomide—skin cancer	0.000761	0.00144	CcSEcCtD
Cilazapril—Paraesthesia—Bleomycin—skin cancer	0.000757	0.00143	CcSEcCtD
Cilazapril—Vomiting—Imiquimod—skin cancer	0.000755	0.00143	CcSEcCtD
Cilazapril—Hypertension—Temozolomide—skin cancer	0.000753	0.00143	CcSEcCtD
Cilazapril—Dyspnoea—Bleomycin—skin cancer	0.000752	0.00142	CcSEcCtD
Cilazapril—Anorexia—Dactinomycin—skin cancer	0.00075	0.00142	CcSEcCtD
Cilazapril—Rash—Imiquimod—skin cancer	0.000749	0.00142	CcSEcCtD
Cilazapril—Dermatitis—Imiquimod—skin cancer	0.000748	0.00142	CcSEcCtD
Cilazapril—Headache—Imiquimod—skin cancer	0.000744	0.00141	CcSEcCtD
Cilazapril—Anaemia—Fluorouracil—skin cancer	0.000743	0.00141	CcSEcCtD
Cilazapril—Arthralgia—Temozolomide—skin cancer	0.000742	0.00141	CcSEcCtD
Cilazapril—Myalgia—Temozolomide—skin cancer	0.000742	0.00141	CcSEcCtD
Cilazapril—Anxiety—Temozolomide—skin cancer	0.00074	0.0014	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000737	0.0014	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000736	0.00139	CcSEcCtD
Cilazapril—Discomfort—Temozolomide—skin cancer	0.000733	0.00139	CcSEcCtD
Cilazapril—Decreased appetite—Bleomycin—skin cancer	0.000733	0.00139	CcSEcCtD
Cilazapril—Acute coronary syndrome—Docetaxel—skin cancer	0.000731	0.00139	CcSEcCtD
Cilazapril—Renal failure—Docetaxel—skin cancer	0.000729	0.00138	CcSEcCtD
Cilazapril—Myocardial infarction—Docetaxel—skin cancer	0.000727	0.00138	CcSEcCtD
Cilazapril—Dry mouth—Temozolomide—skin cancer	0.000726	0.00137	CcSEcCtD
Cilazapril—Pain—Bleomycin—skin cancer	0.000721	0.00137	CcSEcCtD
Cilazapril—Conjunctivitis—Docetaxel—skin cancer	0.000721	0.00137	CcSEcCtD
Cilazapril—Leukopenia—Fluorouracil—skin cancer	0.000719	0.00136	CcSEcCtD
Cilazapril—Confusional state—Temozolomide—skin cancer	0.000718	0.00136	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000717	0.00136	CcSEcCtD
Cilazapril—Oedema—Temozolomide—skin cancer	0.000712	0.00135	CcSEcCtD
Cilazapril—Nausea—Imiquimod—skin cancer	0.000705	0.00134	CcSEcCtD
Cilazapril—Hepatobiliary disease—Docetaxel—skin cancer	0.000702	0.00133	CcSEcCtD
Cilazapril—Epistaxis—Docetaxel—skin cancer	0.0007	0.00133	CcSEcCtD
Cilazapril—Thrombocytopenia—Temozolomide—skin cancer	0.000697	0.00132	CcSEcCtD
Cilazapril—Feeling abnormal—Bleomycin—skin cancer	0.000695	0.00132	CcSEcCtD
Cilazapril—Agranulocytosis—Docetaxel—skin cancer	0.000692	0.00131	CcSEcCtD
Cilazapril—Skin disorder—Temozolomide—skin cancer	0.000691	0.00131	CcSEcCtD
Cilazapril—Hyperhidrosis—Temozolomide—skin cancer	0.000688	0.0013	CcSEcCtD
Cilazapril—Chest pain—Fluorouracil—skin cancer	0.000684	0.0013	CcSEcCtD
Cilazapril—Myalgia—Fluorouracil—skin cancer	0.000684	0.0013	CcSEcCtD
Cilazapril—Decreased appetite—Dactinomycin—skin cancer	0.000684	0.0013	CcSEcCtD
Cilazapril—Fatigue—Dactinomycin—skin cancer	0.000678	0.00128	CcSEcCtD
Cilazapril—Anorexia—Temozolomide—skin cancer	0.000678	0.00128	CcSEcCtD
Cilazapril—Discomfort—Fluorouracil—skin cancer	0.000676	0.00128	CcSEcCtD
Cilazapril—Pain—Dactinomycin—skin cancer	0.000673	0.00127	CcSEcCtD
Cilazapril—Urticaria—Bleomycin—skin cancer	0.00067	0.00127	CcSEcCtD
Cilazapril—Rhinitis—Docetaxel—skin cancer	0.000668	0.00126	CcSEcCtD
Cilazapril—Hypoaesthesia—Docetaxel—skin cancer	0.000663	0.00125	CcSEcCtD
Cilazapril—Confusional state—Fluorouracil—skin cancer	0.000661	0.00125	CcSEcCtD
Cilazapril—Pharyngitis—Docetaxel—skin cancer	0.000661	0.00125	CcSEcCtD
Cilazapril—Urinary tract disorder—Docetaxel—skin cancer	0.000658	0.00125	CcSEcCtD
Cilazapril—Oedema—Fluorouracil—skin cancer	0.000656	0.00124	CcSEcCtD
Cilazapril—Urethral disorder—Docetaxel—skin cancer	0.000653	0.00124	CcSEcCtD
Cilazapril—Feeling abnormal—Dactinomycin—skin cancer	0.000648	0.00123	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000648	0.00123	CcSEcCtD
Cilazapril—Insomnia—Temozolomide—skin cancer	0.000644	0.00122	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dactinomycin—skin cancer	0.000643	0.00122	CcSEcCtD
Cilazapril—Thrombocytopenia—Fluorouracil—skin cancer	0.000642	0.00122	CcSEcCtD
Cilazapril—Visual impairment—Docetaxel—skin cancer	0.000642	0.00122	CcSEcCtD
Cilazapril—Tachycardia—Fluorouracil—skin cancer	0.00064	0.00121	CcSEcCtD
Cilazapril—Paraesthesia—Temozolomide—skin cancer	0.000639	0.00121	CcSEcCtD
Cilazapril—Dyspnoea—Temozolomide—skin cancer	0.000634	0.0012	CcSEcCtD
Cilazapril—Somnolence—Temozolomide—skin cancer	0.000633	0.0012	CcSEcCtD
Cilazapril—Erythema multiforme—Docetaxel—skin cancer	0.00063	0.00119	CcSEcCtD
Cilazapril—Dyspepsia—Temozolomide—skin cancer	0.000626	0.00119	CcSEcCtD
Cilazapril—Anorexia—Fluorouracil—skin cancer	0.000625	0.00118	CcSEcCtD
Cilazapril—Abdominal pain—Dactinomycin—skin cancer	0.000622	0.00118	CcSEcCtD
Cilazapril—Hypersensitivity—Bleomycin—skin cancer	0.000622	0.00118	CcSEcCtD
Cilazapril—Decreased appetite—Temozolomide—skin cancer	0.000619	0.00117	CcSEcCtD
Cilazapril—Flushing—Docetaxel—skin cancer	0.000618	0.00117	CcSEcCtD
Cilazapril—Cardiac disorder—Docetaxel—skin cancer	0.000618	0.00117	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Temozolomide—skin cancer	0.000614	0.00116	CcSEcCtD
Cilazapril—Fatigue—Temozolomide—skin cancer	0.000613	0.00116	CcSEcCtD
Cilazapril—Hypotension—Fluorouracil—skin cancer	0.000613	0.00116	CcSEcCtD
Cilazapril—Pain—Temozolomide—skin cancer	0.000609	0.00115	CcSEcCtD
Cilazapril—Constipation—Temozolomide—skin cancer	0.000609	0.00115	CcSEcCtD
Cilazapril—Asthenia—Bleomycin—skin cancer	0.000605	0.00115	CcSEcCtD
Cilazapril—Angiopathy—Docetaxel—skin cancer	0.000604	0.00114	CcSEcCtD
Cilazapril—ABCB1—lymph node—skin cancer	0.000603	0.00328	CbGeAlD
Cilazapril—Immune system disorder—Docetaxel—skin cancer	0.000602	0.00114	CcSEcCtD
Cilazapril—Chills—Docetaxel—skin cancer	0.000598	0.00113	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000597	0.00113	CcSEcCtD
Cilazapril—Pruritus—Bleomycin—skin cancer	0.000597	0.00113	CcSEcCtD
Cilazapril—Arrhythmia—Docetaxel—skin cancer	0.000595	0.00113	CcSEcCtD
Cilazapril—Insomnia—Fluorouracil—skin cancer	0.000593	0.00112	CcSEcCtD
Cilazapril—Paraesthesia—Fluorouracil—skin cancer	0.000589	0.00111	CcSEcCtD
Cilazapril—Alopecia—Docetaxel—skin cancer	0.000589	0.00111	CcSEcCtD
Cilazapril—Feeling abnormal—Temozolomide—skin cancer	0.000586	0.00111	CcSEcCtD
Cilazapril—Dyspnoea—Fluorouracil—skin cancer	0.000585	0.00111	CcSEcCtD
Cilazapril—Somnolence—Fluorouracil—skin cancer	0.000583	0.0011	CcSEcCtD
Cilazapril—Gastrointestinal pain—Temozolomide—skin cancer	0.000582	0.0011	CcSEcCtD
Cilazapril—Hypersensitivity—Dactinomycin—skin cancer	0.00058	0.0011	CcSEcCtD
Cilazapril—Dyspepsia—Fluorouracil—skin cancer	0.000577	0.00109	CcSEcCtD
Cilazapril—Decreased appetite—Fluorouracil—skin cancer	0.00057	0.00108	CcSEcCtD
Cilazapril—Dysgeusia—Docetaxel—skin cancer	0.000568	0.00108	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000566	0.00107	CcSEcCtD
Cilazapril—Urticaria—Temozolomide—skin cancer	0.000565	0.00107	CcSEcCtD
Cilazapril—Asthenia—Dactinomycin—skin cancer	0.000564	0.00107	CcSEcCtD
Cilazapril—Abdominal pain—Temozolomide—skin cancer	0.000563	0.00107	CcSEcCtD
Cilazapril—Pain—Fluorouracil—skin cancer	0.000561	0.00106	CcSEcCtD
Cilazapril—Muscle spasms—Docetaxel—skin cancer	0.000557	0.00106	CcSEcCtD
Cilazapril—Feeling abnormal—Fluorouracil—skin cancer	0.00054	0.00102	CcSEcCtD
Cilazapril—Diarrhoea—Dactinomycin—skin cancer	0.000538	0.00102	CcSEcCtD
Cilazapril—Vomiting—Bleomycin—skin cancer	0.000536	0.00102	CcSEcCtD
Cilazapril—Anaemia—Docetaxel—skin cancer	0.000536	0.00101	CcSEcCtD
Cilazapril—Rash—Bleomycin—skin cancer	0.000532	0.00101	CcSEcCtD
Cilazapril—Dermatitis—Bleomycin—skin cancer	0.000531	0.00101	CcSEcCtD
Cilazapril—Hypersensitivity—Temozolomide—skin cancer	0.000524	0.000993	CcSEcCtD
Cilazapril—Urticaria—Fluorouracil—skin cancer	0.000521	0.000986	CcSEcCtD
Cilazapril—Syncope—Docetaxel—skin cancer	0.00052	0.000985	CcSEcCtD
Cilazapril—Leukopenia—Docetaxel—skin cancer	0.000519	0.000983	CcSEcCtD
Cilazapril—Palpitations—Docetaxel—skin cancer	0.000512	0.00097	CcSEcCtD
Cilazapril—Asthenia—Temozolomide—skin cancer	0.000511	0.000967	CcSEcCtD
Cilazapril—Loss of consciousness—Docetaxel—skin cancer	0.00051	0.000965	CcSEcCtD
Cilazapril—Cough—Docetaxel—skin cancer	0.000506	0.000958	CcSEcCtD
Cilazapril—Pruritus—Temozolomide—skin cancer	0.000503	0.000953	CcSEcCtD
Cilazapril—Nausea—Bleomycin—skin cancer	0.000501	0.000949	CcSEcCtD
Cilazapril—Hypertension—Docetaxel—skin cancer	0.000501	0.000948	CcSEcCtD
Cilazapril—Vomiting—Dactinomycin—skin cancer	0.0005	0.000947	CcSEcCtD
Cilazapril—Rash—Dactinomycin—skin cancer	0.000496	0.000939	CcSEcCtD
Cilazapril—Arthralgia—Docetaxel—skin cancer	0.000494	0.000935	CcSEcCtD
Cilazapril—Chest pain—Docetaxel—skin cancer	0.000494	0.000935	CcSEcCtD
Cilazapril—Myalgia—Docetaxel—skin cancer	0.000494	0.000935	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00049	0.000928	CcSEcCtD
Cilazapril—Diarrhoea—Temozolomide—skin cancer	0.000487	0.000922	CcSEcCtD
Cilazapril—Hypersensitivity—Fluorouracil—skin cancer	0.000483	0.000915	CcSEcCtD
Cilazapril—Dry mouth—Docetaxel—skin cancer	0.000483	0.000914	CcSEcCtD
Cilazapril—Confusional state—Docetaxel—skin cancer	0.000477	0.000904	CcSEcCtD
Cilazapril—Oedema—Docetaxel—skin cancer	0.000473	0.000896	CcSEcCtD
Cilazapril—Dizziness—Temozolomide—skin cancer	0.000471	0.000891	CcSEcCtD
Cilazapril—Nausea—Dactinomycin—skin cancer	0.000467	0.000885	CcSEcCtD
Cilazapril—Shock—Docetaxel—skin cancer	0.000466	0.000882	CcSEcCtD
Cilazapril—Pruritus—Fluorouracil—skin cancer	0.000464	0.000878	CcSEcCtD
Cilazapril—Thrombocytopenia—Docetaxel—skin cancer	0.000463	0.000877	CcSEcCtD
Cilazapril—Tachycardia—Docetaxel—skin cancer	0.000462	0.000875	CcSEcCtD
Cilazapril—Skin disorder—Docetaxel—skin cancer	0.00046	0.00087	CcSEcCtD
Cilazapril—Vomiting—Temozolomide—skin cancer	0.000452	0.000857	CcSEcCtD
Cilazapril—Anorexia—Docetaxel—skin cancer	0.000451	0.000854	CcSEcCtD
Cilazapril—Rash—Temozolomide—skin cancer	0.000449	0.00085	CcSEcCtD
Cilazapril—Diarrhoea—Fluorouracil—skin cancer	0.000449	0.000849	CcSEcCtD
Cilazapril—Dermatitis—Temozolomide—skin cancer	0.000448	0.000849	CcSEcCtD
Cilazapril—Headache—Temozolomide—skin cancer	0.000446	0.000844	CcSEcCtD
Cilazapril—Hypotension—Docetaxel—skin cancer	0.000442	0.000837	CcSEcCtD
Cilazapril—Dizziness—Fluorouracil—skin cancer	0.000434	0.000821	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000431	0.000816	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—skin cancer	0.000428	0.000811	CcSEcCtD
Cilazapril—Paraesthesia—Docetaxel—skin cancer	0.000425	0.000805	CcSEcCtD
Cilazapril—Nausea—Temozolomide—skin cancer	0.000423	0.0008	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—skin cancer	0.000422	0.000799	CcSEcCtD
Cilazapril—Somnolence—Docetaxel—skin cancer	0.000421	0.000797	CcSEcCtD
Cilazapril—Vomiting—Fluorouracil—skin cancer	0.000417	0.000789	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—skin cancer	0.000417	0.000789	CcSEcCtD
Cilazapril—Rash—Fluorouracil—skin cancer	0.000413	0.000783	CcSEcCtD
Cilazapril—Dermatitis—Fluorouracil—skin cancer	0.000413	0.000782	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—skin cancer	0.000411	0.000779	CcSEcCtD
Cilazapril—Headache—Fluorouracil—skin cancer	0.000411	0.000778	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—skin cancer	0.000409	0.000774	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—skin cancer	0.000408	0.000773	CcSEcCtD
Cilazapril—Pain—Docetaxel—skin cancer	0.000405	0.000766	CcSEcCtD
Cilazapril—Constipation—Docetaxel—skin cancer	0.000405	0.000766	CcSEcCtD
Cilazapril—Feeling abnormal—Docetaxel—skin cancer	0.00039	0.000738	CcSEcCtD
Cilazapril—Nausea—Fluorouracil—skin cancer	0.000389	0.000737	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—skin cancer	0.000387	0.000733	CcSEcCtD
Cilazapril—Abdominal pain—Docetaxel—skin cancer	0.000374	0.000708	CcSEcCtD
Cilazapril—Hypersensitivity—Docetaxel—skin cancer	0.000349	0.00066	CcSEcCtD
Cilazapril—Asthenia—Docetaxel—skin cancer	0.00034	0.000643	CcSEcCtD
Cilazapril—Pruritus—Docetaxel—skin cancer	0.000335	0.000634	CcSEcCtD
Cilazapril—Diarrhoea—Docetaxel—skin cancer	0.000324	0.000613	CcSEcCtD
Cilazapril—Dizziness—Docetaxel—skin cancer	0.000313	0.000593	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—skin cancer	0.000301	0.00057	CcSEcCtD
Cilazapril—Rash—Docetaxel—skin cancer	0.000298	0.000565	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—skin cancer	0.000298	0.000564	CcSEcCtD
Cilazapril—Headache—Docetaxel—skin cancer	0.000296	0.000561	CcSEcCtD
Cilazapril—Nausea—Docetaxel—skin cancer	0.000281	0.000532	CcSEcCtD
